株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

生体機能チップ (Organs-on-chip) の世界市場 2022年:生理学的モデル開発・創薬・毒物学的研究

Organs-on-chips Market by Type (Liver, Kidney, Lung, Heart, Intestines, Gut), Offering (Product, Service), Application (Toxicity testing, Physiological model), End User (Academic, Research Institute, Pharma companies) - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 600133
出版日 ページ情報 英文 119 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。
生体機能チップ (Organs-on-chip) の世界市場 2022年:生理学的モデル開発・創薬・毒物学的研究 Organs-on-chips Market by Type (Liver, Kidney, Lung, Heart, Intestines, Gut), Offering (Product, Service), Application (Toxicity testing, Physiological model), End User (Academic, Research Institute, Pharma companies) - Global Forecast to 2022
出版日: 2018年01月12日 ページ情報: 英文 119 Pages
概要

世界の生体機能チップ (Organs-on-chip) 市場は、2017年の960万米ドルから2022年までに4560万米ドルへ、36.6%のCAGR (年間複合成長率) で成長すると予測されています。動物実験モデルに代わる方法の開発に対する関心の高まり、生体機能チップの開発に対する研究資金・ベンチャーキャピタル投資の大幅な増加、および技術進歩と製品発売などは、同市場を促進する要因となっています。しかし、既存ワークフローへ生体機能チップ技術を取り込むことに関連した課題、および生体機能チップモデルの複雑性は、近い将来の市場成長を抑制する可能性があります。

当レポートでは、世界の生体機能チップ (Organs-on-chip) 市場について調査し、市場概要、各セグメント・地域別による市場分析と予測、競合情勢、および主要企業のプロファイルなど、体系的な情報を提供しています。

FIGURE 11 ORGANS-ON-CHIPS MARKET

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 生体機能チップ市場概要
  • 欧州の生体機能チップ市場:アプリケーション・国別
  • 生体機能チップ市場:種類別
  • 生体機能チップ市場:アプリケーション別

第5章 市場概要

  • イントロダクション
  • 市場動態
    • 推進要因
    • 抑制要因
    • 機会
    • 課題
  • 資金・ベンチャーキャピタル投資

第6章 生体機能チップ市場:種類別

  • イントロダクション
  • 肝臓
  • 心臓
  • 腎臓
  • その他の臓器

第7章 生体機能チップ市場:提供物別

  • イントロダクション
  • 製品
  • サービス

第8章 生体機能チップ市場:アプリケーション別

  • イントロダクション
  • 生理学的モデル開発
  • 創薬
  • 毒物学的研究

第9章 生体機能チップ市場:エンドユーザー別

  • イントロダクション
  • 医薬品・バイオテクノロジー企業
  • 大学・研究機関
  • 化粧品産業
  • その他のエンドユーザー

第10章 生体機能チップ市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア
  • その他

第11章 競合情勢

  • イントロダクション
  • 主要企業ランキング
  • 競合状況・動向

第12章 企業プロファイル

  • EMULATE
  • CN BIO
  • TISSUSE
  • MIMETAS
  • INSPHERO
  • ASCENDANCE BIO
  • KIRKSTALL
  • HUREL
  • SYNVIVO
  • AXOSIM
  • NORTIS

第13章 付録

図表

LIST OF TABLES

  • TABLE 1: KEY PRODUCT LAUNCHES/UPGRADES
  • TABLE 2: FUNDING & VENTURE CAPITAL INVESTMENTS
  • TABLE 3: ORGANS-ON-CHIPS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 4: LIVER-ON-A-CHIP MARKET, BY REGION, 2015-2022 (USD THOUSAND)
  • TABLE 5: NORTH AMERICA: LIVER-ON-A-CHIP MARKET, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 6: HEART-ON-A-CHIP MARKET, BY REGION, 2015-2022 (USD THOUSAND)
  • TABLE 7: NORTH AMERICA: HEART-ON-A-CHIP MARKET, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 8: LUNG-ON-A-CHIP MARKET, BY REGION, 2015-2022 (USD THOUSAND)
  • TABLE 9: NORTH AMERICA: LUNG-ON-A-CHIPS MARKET, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 10: KIDNEY-ON-A-CHIP MARKET, BY REGION, 2015-2022 (USD THOUSAND)
  • TABLE 11: NORTH AMERICA: KIDNEY-ON-A-CHIP MARKET, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 12: OTHER ORGANS-ON-CHIPS MARKET, BY REGION, 2015-2022 (USD THOUSAND)
  • TABLE 13: NORTH AMERICA: OTHER ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 14: ORGANS-ON-CHIPS MARKET, BY OFFERING, 2015-2022 (USD MILLION)
  • TABLE 15: NORTH AMERICA: ORGANS-ON-CHIPS PRODUCTS MARKET, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 16: NORTH AMERICA: ORGANS-ON-CHIPS SERVICES MARKET, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 17: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 18: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY REGION, 2015-2022 (USD THOUSAND)
  • TABLE 19: NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 20: EUROPE: ORGANS-ON-CHIPS MARKET FOR PHYSIOLOGICAL MODEL DEVELOPMENT, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 21: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY REGION, 2015-2022 (USD THOUSAND)
  • TABLE 22: NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 23: EUROPE: ORGANS-ON-CHIPS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 24: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY REGION, 2015-2022 (USD THOUSAND)
  • TABLE 25: NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 26: EUROPE: ORGANS-ON-CHIPS MARKET FOR TOXICOLOGY RESEARCH, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 27: ORGANS-ON-CHIPS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 28: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2015-2022 (USD THOUSAND)
  • TABLE 29: NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 30: EUROPE: ORGANS-ON-CHIPS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 31: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2015-2022 (USD THOUSAND)
  • TABLE 32: NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 33: EUROPE: ORGANS-ON-CHIPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 34: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY REGION, 2015-2022 (USD THOUSAND)
  • TABLE 35: NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 36: EUROPE: ORGANS-ON-CHIPS MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 37: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY REGION, 2015-2022 (USD THOUSAND)
  • TABLE 38: NORTH AMERICA: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 39: EUROPE: ORGANS-ON-CHIPS MARKET FOR OTHER END USERS, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 40: ORGANS-ON-CHIPS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 41: NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 42: NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY TYPE, 2015-2022 (USD THOUSAND)
  • TABLE 43: NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY OFFERING, 2015-2022 (USD THOUSAND)
  • TABLE 44: NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2015-2022 (USD THOUSAND)
  • TABLE 45: NORTH AMERICA: ORGANS-ON-CHIPS MARKET, BY END USER, 2015-2022 (USD THOUSAND)
  • TABLE 46: US: ORGANS-ON-CHIPS MARKET, BY OFFERING, 2015-2022 (USD THOUSAND)
  • TABLE 47: US: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2015-2022 (USD THOUSAND)
  • TABLE 48: US: ORGANS-ON-CHIPS MARKET, BY END USER, 2015-2022 (USD THOUSAND)
  • TABLE 49: CANADA: ORGANS-ON-CHIPS MARKET, BY OFFERING, 2015-2022 (USD THOUSAND)
  • TABLE 50: CANADA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2015-2022 (USD THOUSAND)
  • TABLE 51: CANADA: ORGANS-ON-CHIPS MARKET, BY END USER, 2015-2022 (USD THOUSAND)
  • TABLE 52: EUROPE: ORGANS-ON-CHIPS MARKET, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 53: EUROPE: ORGANS-ON-CHIPS MARKET, BY TYPE, 2015-2022 (USD THOUSAND)
  • TABLE 54: EUROPE: ORGANS-ON-CHIPS MARKET, BY OFFERING, 2015-2022 (USD THOUSAND)
  • TABLE 55: EUROPE: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2015-2022 (USD THOUSAND)
  • TABLE 56: EUROPE: ORGANS-ON-CHIPS MARKET, BY END USER, 2015-2022 (USD THOUSAND)
  • TABLE 57: GERMANY: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2015-2022 (USD THOUSAND)
  • TABLE 58: GERMANY: ORGANS-ON-CHIPS MARKET, BY END USER, 2015-2022 (USD THOUSAND)
  • TABLE 59: UK: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2015-2022 (USD THOUSAND)
  • TABLE 60: UK: ORGANS-ON-CHIPS MARKET, BY END USER, 2015-2022 (USD THOUSAND)
  • TABLE 61: ROE: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2015-2022 (USD THOUSAND)
  • TABLE 62: ROE: ORGANS-ON-CHIPS MARKET, BY END USER, 2015-2022 (USD THOUSAND)
  • TABLE 63: ASIA: ORGANS-ON-CHIPS MARKET, BY TYPE, 2015-2022 (USD THOUSAND)
  • TABLE 64: ASIA: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2015-2022 (USD THOUSAND)
  • TABLE 65: ASIA: ORGANS-ON-CHIPS MARKET, BY END USER, 2015-2022 (USD THOUSAND)
  • TABLE 66: ROW: ORGANS-ON-CHIPS MARKET, BY APPLICATION, 2015-2022 (USD THOUSAND)
  • TABLE 67: ROW: ORGANS-ON-CHIPS MARKET, BY END USER, 2015-2022 (USD THOUSAND)
  • TABLE 68: ORGANS-ON-CHIPS MARKET RANKING ANALYSIS, BY KEY PLAYER (2016)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BOTTOM-UP APPROACH
  • FIGURE 3: TOP-DOWN APPROACH
  • FIGURE 4: BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: LIVER-ON-A-CHIP MARKET TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 7: SERVICES SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 8: DRUG DISCOVERY SEGMENT TO REGISTER THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 9: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE ORGANS-ON-CHIPS END-USER MARKET DURING THE FORECAST PERIOD
  • FIGURE 10: NORTH AMERICA TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD (2017-2022)
  • FIGURE 11: FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING TO DRIVE THE GROWTH OF THE MARKET
  • FIGURE 12: TOXICOLOGY RESEARCH TO HOLD THE LARGEST SHARE OF THE ORGANS-ON-CHIPS MARKET IN EUROPE(2017)
  • FIGURE 13: LIVER SEGMENT TO WITNESS HIGH GROWTH FROM 2017 TO 2022
  • FIGURE 14: TOXICOLOGY RESEARCH SEGMENT TO DOMINATE THE ORGANS-ON-CHIPS MARKET IN 2017
  • FIGURE 15: ORGANS-ON-CHIPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: NUMBER OF REGISTERED CLINICAL TRIAL STUDIES (2005-2017)
  • FIGURE 17: LIVER SEGMENT TO DOMINATE THE ORGANS-ON-CHIPS MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: SERVICES SEGMENT TO DOMINATE THE ORGANS-ON-CHIPS MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: TOXICOLOGY RESEARCH IS ESTIMATED TO BE THE LARGEST APPLICATION SEGMENT IN THE ORGANS-ON-CHIPS MARKET
  • FIGURE 20: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES WILL CONTINUE TO DOMINATE THE ORGANS-ON-CHIPS MARKET IN 2022
  • FIGURE 21: NORTH AMERICA WILL CONTINUE TO DOMINATE THE ORGANS-ON-CHIPS MARKET IN 2022
  • FIGURE 22: NORTH AMERICA: ORGANS-ON-CHIPS MARKET SNAPSHOT
  • FIGURE 23: EUROPE: ORGANS-ON-CHIPS MARKET SNAPSHOT
  • FIGURE 24: ASIA: ORGANS-ON-CHIPS MARKET SNAPSHOT
  • FIGURE 25: ROW: ORGANS-ON-CHIPS MARKET SNAPSHOT
  • FIGURE 26: STRATEGIES ADOPTED BY MARKET PLAYERS (2014-2017)
  • FIGURE 27: MARKET EVOLUTION FRAMEWORK
目次
Product Code: BT 5883

The global organs-on-chips market projected to grow at a CAGR of 36.6%.

The organs-on-chips market is expected to reach USD 45.6 million by 2022 from USD 9.6 million in 2017, at a CAGR of 36.6%. Focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of organs-on-chips, technological advancements and products launches, growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers, and growing need for early detection of drug toxicity to minimize financial losses due to late stage drug failure are some of the factors driving the growth of the market. On the other hand, issues related to the incorporation of organs-on-chips technologies into existing workflows, and complexity of organs-on-chips models may limit market growth to a certain extent in the coming years.

Services segment are expected to hold the largest share of the market in 2017.

Based on offering, the organs-on-chips market is segmented into products and services. The services segment is expected to dominate this market and is also expected to grow at the highest CAGR during the forecast period. The dearth of skilled professionals and the lack of the necessary R&D infrastructure to handle and interpret results obtained by using OOC systems, coupled with the increasing research outsourcing by pharmaceutical and biotechnology companies are driving the high growth of the services segment.

The toxicology research segment is expected to dominate the market during the forecast period.

Based on application, the market is segmented into physiological model development, drug discovery, and toxicology research. The toxicology research segment is expected to dominate the market during the forecast period. The increasing efforts for replacing animal toxicity studies by developing more efficient and accurate alternatives are expected to drive the growth of the toxicology research segment during the forecast period.

North America to witness high growth during the forecast period.

In 2017, North America is expected to account for the largest share and also expected to grow at the highest CAGR of the market followed by Europe. The largest share and high growth of this market is attributed to factors such as the availability of new and advanced organs-on-chips models in the market, favorable government initiatives in terms of funding and programs for basic drug development and research, and the presence of key pharmaceutical companies.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 25%; Tier 2 - 30%; Tier 3 - 45%.
  • By Designation: C-level- 25%; D-level- 40%; others- 35%.
  • By Region: North America-41%; Europe-30%; Asia-24%; RoW: 5%

List of companies profiled in the report:

  • CN Bio (UK)
  • Emulate (US)
  • TissUse (Germany)
  • Mimetas (Netherlands)
  • InSphero (Switzerland)
  • Ascendance Bio (US)
  • Kirkstall (UK)
  • HUREL (US)
  • SynVivo (US)
  • AxoSim (US)
  • Nortis (US)

Research Coverage:

The report provides an overview of the organs-on-chips market. It aims at estimating the market size and future growth potential of this market across different segments such as type, offerings, application, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall organs-on-chips market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ORGANS-ON-CHIPS MARKET OVERVIEW
  • 4.2 EUROPE: ORGANS-ON-CHIPS MARKET, BY APPLICATION & COUNTRY
  • 4.3 ORGANS-ON-CHIPS MARKET, BY TYPE
  • 4.4 ORGANS-ON-CHIPS MARKET, BY APPLICATION

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing focus on developing alternatives for animal testing models
      • 5.2.1.2 Significant increase in research funding and venture capital investments for the development of organs-on-chips
      • 5.2.1.3 Technological advancements and new products launches
      • 5.2.1.4 Growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers
      • 5.2.1.5 Growing need for early detection of drug toxicity to minimize financial losses due to late stage drug failure
      • 5.2.1.6 Growing initiatives to increase awareness about organs-on-chips technologies
    • 5.2.2 RESTRAINT
      • 5.2.2.1 Issues related to the incorporation of organs-on-chips technologies into existing workflows
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing focus on drug discovery activities
      • 5.2.3.2 Application of organs-on-chips in oncology research
      • 5.2.3.3 Development of multiple-organs-on-a-chip models
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Complexity of organs-on-chips models
      • 5.2.4.2 Dearth of skilled professionals
  • 5.3 FUNDING AND VENTURE CAPITAL INVESTMENTS

6 ORGANS-ON-CHIPS MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 LIVER
  • 6.3 HEART
  • 6.4 LUNG
  • 6.5 KIDNEY
  • 6.6 OTHER ORGANS

7 ORGANS-ON-CHIPS MARKET, BY OFFERING

  • 7.1 INTRODUCTION
  • 7.2 PRODUCTS
  • 7.3 SERVICES

8 ORGANS-ON-CHIPS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 PHYSIOLOGICAL MODEL DEVELOPMENT
  • 8.3 DRUG DISCOVERY
  • 8.4 TOXICOLOGY RESEARCH

9 ORGANS-ON-CHIPS MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 9.3 ACADEMIC & RESEARCH INSTITUTES
  • 9.4 COSMETICS INDUSTRY
  • 9.5 OTHER END USERS

10 ORGANS-ON-CHIPS MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
    • 10.2.2 CANADA
  • 10.3 EUROPE
    • 10.3.1 GERMANY
    • 10.3.2 UK
    • 10.3.3 ROE
  • 10.4 ASIA
  • 10.5 REST OF THE WORLD

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 RANKING OF PLAYERS, 2016
  • 11.3 COMPETITIVE SITUATION AND TRENDS
    • 11.3.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 11.3.2 PRODUCT LAUNCHES
    • 11.3.3 EXPANSIONS

12 COMPANY PROFILES

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1 EMULATE
  • 12.2 CN BIO
  • 12.3 TISSUSE
  • 12.4 MIMETAS
  • 12.5 INSPHERO
  • 12.6 ASCENDANCE BIO
  • 12.7 KIRKSTALL
  • 12.8 HUREL
  • 12.9 SYNVIVO
  • 12.10 AXOSIM
  • 12.11 NORTIS

Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 13.2 DISCUSSION GUIDE
  • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5 AVAILABLE CUSTOMIZATIONS
  • 13.6 RELATED REPORTS
  • 13.7 AUTHOR DETAILS